Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CHRS Coherus Biosciences

盘后交易 12-23 16:43:18 EST

1.32

-0.08

-5.71%

盘后1.32

+0.000.00%

16:10 EST

最高1.40	最低1.30	成交量79.40万
今开1.40	昨收1.40	日振幅7.14%
总市值1.60亿	流通市值1.47亿	总股本1.21亿
成交额106.22万	换手率0.71%	流通股本1.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CHRS","market":"US","secType":"STK","nameCN":"Coherus Biosciences","latestPrice":1.32,"timestamp":1766523600000,"preClose":1.4,"halted":0,"volume":793971,"hourTrading":{"tag":"盘后","latestPrice":1.32,"preClose":1.32,"latestTime":"16:10 EST","volume":6267,"amount":8271.7681776,"timestamp":1766524204790},"delay":0,"floatShares":111186184,"shares":120871013,"eps":1.337129,"marketStatus":"盘后交易","change":-0.08,"latestTime":"12-23 16:43:18 EST","open":1.4,"high":1.4,"low":1.3,"amount":1062174.800785,"amplitude":0.071429,"askPrice":1.57,"askSize":100,"bidPrice":1.29,"bidSize":250,"shortable":3,"etf":0,"ttmEps":1.337129,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766538000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1415250000000,"exchange":"NASDAQ","adjPreClose":1.4,"preHourTrading":{"tag":"盘前","latestPrice":1.4,"preClose":1.4,"latestTime":"09:29 EST","volume":113,"amount":158.2,"timestamp":1766500199913},"postHourTrading":{"tag":"盘后","latestPrice":1.32,"preClose":1.32,"latestTime":"16:10 EST","volume":6267,"amount":8271.7681776,"timestamp":1766524204790},"volumeRatio":1.037658,"impliedVol":2.3368,"impliedVolPercentile":0.752},"requestUrl":"/m/hq/s/CHRS","defaultTab":"news","newsList":[{"id":"1101132122","title":"Coherus公布六年Jupiter-02随访结果显示Loqtorzi®联合化疗几乎使鼻咽癌的中位整体生存期增加一倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1101132122","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101132122?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:33","pubTimestamp":1765200807,"startTime":"0","endTime":"0","summary":"Coherus公布六年Jupiter-02随访结果显示，Loqtorzi®联合化疗几乎使鼻咽癌的中位整体生存期增加一倍。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"1183845036","title":"Coherus Oncology第三季度销售额为1157.1万美元，低于IBES预期的1340万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183845036","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183845036?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:03","pubTimestamp":1763571828,"startTime":"0","endTime":"0","summary":"11月6日消息，Coherus Oncology第三季度净亏损为3553.1万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2584196351","title":"Coherus Oncology, Inc.盘中异动 临近午盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584196351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584196351?lang=zh_cn&edition=full","pubTime":"2025-11-19 00:57","pubTimestamp":1763485057,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日00时57分，Coherus Oncology, Inc.股票出现波动，股价快速拉升5.30%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119005737950c9adf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119005737950c9adf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2583066737","title":"Coherus Oncology, Inc.2025财年第三财季实现净利润-44.52百万美元，同比减少314.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583066737","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583066737?lang=zh_cn&edition=full","pubTime":"2025-11-16 00:02","pubTimestamp":1763222555,"startTime":"0","endTime":"0","summary":"11月16日，Coherus Oncology, Inc.公布财报，公告显示公司2025财年第三财季净利润为-44.52百万美元，同比减少314.14%；其中营业收入为11.57百万美元，同比减少83.65%，每股基本收益为-0.30美元。从资产负债表来看，Coherus Oncology, Inc.总负债4.29亿美元，其中短期债务1.79百万美元，资产负债比为1.21，流动比率为1.24。机构评级：截至2025年11月16日，当前有3家机构对Coherus Oncology, Inc.目标价做出预测，其中目标均价为5.67美元，其中最低目标价为4.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116000328a6fbb5a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116000328a6fbb5a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2568291938","title":"Coherus Oncology, Inc.盘中异动 股价大涨9.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568291938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568291938?lang=zh_cn&edition=full","pubTime":"2025-09-19 21:31","pubTimestamp":1758288697,"startTime":"0","endTime":"0","summary":"北京时间2025年09月19日21时31分，Coherus Oncology, Inc.股票出现异动，股价快速上涨9.80%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919213137a72a643b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919213137a72a643b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2558665766","title":"Coherus Oncology, Inc.盘中异动 早盘快速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558665766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558665766?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:42","pubTimestamp":1754919766,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时42分，Coherus Oncology, Inc.股票出现异动，股价急速拉升5.17%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。消息层面，截至21时42分，《英特萨斯制药公司从科赫勒斯生物科学公司收购UDENYCA生物类似药培非格司亭Intas Pharmaceuticals Acquires UDENYCA Biosimilar Pegfilgrastim from Coherus BioSciences》资讯为影响Coherus Oncology, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811214246a6dfbcf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811214246a6dfbcf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2557578400","title":"Coherus Oncology, Inc.盘中异动 早盘急速下挫5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557578400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557578400?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:31","pubTimestamp":1754663494,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时31分，Coherus Oncology, Inc.股票出现异动，股价快速下挫5.98%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。消息层面，截至22时31分，《英特萨斯制药公司从科赫勒斯生物科学公司收购UDENYCA生物类似药培非格司亭Intas Pharmaceuticals Acquires UDENYCA Biosimilar Pegfilgrastim from Coherus BioSciences》资讯为影响Coherus Oncology, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808223134a6db3820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808223134a6db3820&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2556811142","title":"Coherus Oncology, Inc.盘中异动 早盘股价大跌5.07%报0.893美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556811142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556811142?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:56","pubTimestamp":1754056577,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时56分，Coherus Oncology, Inc.股票出现异动，股价大幅下跌5.07%。截至发稿，该股报0.893美元/股，成交量41.6381万股，换手率0.36%，振幅6.36%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801215618a46feb85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801215618a46feb85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2555029485","title":"Coherus Oncology, Inc.盘中异动 急速跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555029485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555029485?lang=zh_cn&edition=full","pubTime":"2025-07-31 03:01","pubTimestamp":1753902105,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时01分，Coherus Oncology, Inc.股票出现异动，股价急速下跌5.14%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731030145a46c0367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731030145a46c0367&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2554770148","title":"Coherus Oncology, Inc.盘中异动 早盘股价大涨5.77%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554770148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554770148?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:01","pubTimestamp":1753711316,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时01分，Coherus Oncology, Inc.股票出现异动，股价快速拉升5.77%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728220157a467e47e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728220157a467e47e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2551912638","title":"Coherus Oncology, Inc.盘中异动 快速上涨5.34%报0.895美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551912638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551912638?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:38","pubTimestamp":1752673095,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时38分，Coherus Oncology, Inc.股票出现波动，股价大幅上涨5.34%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162138159544ec55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162138159544ec55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2551708180","title":"Coherus Oncology, Inc.盘中异动 急速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551708180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551708180?lang=zh_cn&edition=full","pubTime":"2025-07-15 00:42","pubTimestamp":1752511329,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日00时42分，Coherus Oncology, Inc.股票出现波动，股价快速上涨5.14%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715004209954255bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715004209954255bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2550283951","title":"Coherus Oncology, Inc.盘中异动 大幅拉升5.04%报0.911美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550283951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550283951?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:08","pubTimestamp":1752242911,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时08分，Coherus Oncology, Inc.股票出现异动，股价快速上涨5.04%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。消息层面，截至22时08分，《储亿银行维持Coherus Oncology买入评级》资讯为影响Coherus Oncology, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711220832a4450cc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711220832a4450cc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2550659301","title":"Coherus Oncology, Inc.盘中异动 早盘股价大涨5.64%报0.858美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659301?lang=zh_cn&edition=full","pubTime":"2025-07-09 23:03","pubTimestamp":1752073380,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日23时03分，Coherus Oncology, Inc.股票出现异动，股价急速拉升5.64%。截至发稿，该股报0.858美元/股，成交量34.9674万股，换手率0.30%，振幅6.13%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230300a69fafea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230300a69fafea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2549555844","title":"Coherus Oncology, Inc.盘中异动 早盘急速下跌5.40%报0.766美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549555844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549555844?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:26","pubTimestamp":1751898392,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时26分，Coherus Oncology, Inc.股票出现波动，股价快速跳水5.40%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707222633a69b2e51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707222633a69b2e51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2548814723","title":"Coherus Oncology, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548814723","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548814723?lang=zh_cn&edition=full","pubTime":"2025-07-03 02:21","pubTimestamp":1751480486,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日02时21分，Coherus Oncology, Inc.股票出现波动，股价快速拉升5.01%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070302212695343a1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070302212695343a1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2546281687","title":"Coherus Oncology, Inc.盘中异动 大幅上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546281687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546281687?lang=zh_cn&edition=full","pubTime":"2025-06-28 00:23","pubTimestamp":1751041394,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日00时23分，Coherus Oncology, Inc.股票出现波动，股价快速上涨5.13%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628002314a4c198a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628002314a4c198a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2546286662","title":"Coherus Oncology, Inc.盘中异动 快速下挫5.17%报0.728美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546286662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546286662?lang=zh_cn&edition=full","pubTime":"2025-06-26 02:13","pubTimestamp":1750875185,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日02时13分，Coherus Oncology, Inc.股票出现异动，股价大幅下跌5.17%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626021305978ec2fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626021305978ec2fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2545236568","title":"Coherus Oncology, Inc.盘中异动 早盘快速上涨5.04%报0.763美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545236568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545236568?lang=zh_cn&edition=full","pubTime":"2025-06-24 22:33","pubTimestamp":1750775585,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日22时33分，Coherus Oncology, Inc.股票出现异动，股价急速上涨5.04%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624223305978cfb2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624223305978cfb2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2544671993","title":"Coherus Oncology, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544671993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544671993?lang=zh_cn&edition=full","pubTime":"2025-06-17 21:48","pubTimestamp":1750168109,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日21时48分，Coherus Oncology, Inc.股票出现异动，股价快速下跌5.09%。Coherus Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Coherus Oncology, Inc.公司简介：Coherus Oncology Inc是一家全方位整合的商业阶段创新型肿瘤学公司，拥有已获批的下一代PD-1抑制剂LOQTORZI以及一条包括两款针对肝癌、肺癌、头颈癌和其他癌症的中期临床候选药物在内的管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061721482997837bd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061721482997837bd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.coherus.com","stockEarnings":[{"period":"1week","weight":0.0072},{"period":"1month","weight":0.2069},{"period":"3month","weight":-0.1026},{"period":"6month","weight":0.9417},{"period":"1year","weight":-0.0789},{"period":"ytd","weight":0.0145}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0326},{"period":"6month","weight":0.128},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1685}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Coherus Oncology, Inc.于2010年9月在特拉华州注册成立。该公司是一家商业阶段的生物制药公司，专注于创新癌症治疗的研究、开发和商业化以及已获批准的生物类似物组合的商业化。该公司的战略是建立一个领先的免疫肿瘤专营权，其资金来自通过净销售美国食品和药物管理局批准的疗法的多元化组合所产生的现金。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.000743},{"month":2,"riseRate":0.454545,"avgChangeRate":0.005379},{"month":3,"riseRate":0.454545,"avgChangeRate":0.004197},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.031006},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.027386},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.017822},{"month":7,"riseRate":0.545455,"avgChangeRate":0.104665},{"month":8,"riseRate":0.818182,"avgChangeRate":0.118971},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.092992},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.062607},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.005438},{"month":12,"riseRate":0.583333,"avgChangeRate":0.039405}],"exchange":"NASDAQ","name":"Coherus Biosciences","nameEN":"Coherus BioSciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Coherus Biosciences,CHRS,Coherus Biosciences股票,Coherus Biosciences股票老虎,Coherus Biosciences股票老虎国际,Coherus Biosciences行情,Coherus Biosciences股票行情,Coherus Biosciences股价,Coherus Biosciences股市,Coherus Biosciences股票价格,Coherus Biosciences股票交易,Coherus Biosciences股票购买,Coherus Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}